Olivenhain, CA, United States of America

Nicholas M Dean

USPTO Granted Patents = 54 (Patent Applications = 8)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 2.7

ph-index = 19

Forward Citations = 2,102(Granted Patents)

Forward Citations (Not Self Cited) = 2,068(Oct 12, 2025)

Inventors with similar research interests:

Location History:

Cardiff-by-the-Sea, CA (US) (1997 - 2000)
Carlsbad, CA (US) (2008)
Olivenhain, CA (US) (1999 - 2015)
Encinitas, CA (US) (1998 - 2017)

Company Filing History:

48 out of 1,035

Isis Pharmaceuticals, Inc.

patents

6 out of 6

Excaliard Pharmaceuticals, Inc.

patents

2 out of 122

Sarepta Therapeutics, Inc.

South Alabama Medical Science Foundation

Northwestern University

patents

9. 1 out of 17

Antisense Therapeutics Limited

patents

10. 1 out of 270

Ionis Pharmaceuticals, Inc.

patents

11. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2017

Loading Chart...

54 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9688987 - Antisense oligonucleotides directed against connective tissue growth factor and uses thereof (2017-06-27),

2. 9173894 - Method of treating keloids or hypertrophic scars using antisense compounds targeting connective tissue growth factor (CTGF) (2015-11-03),

3. 9157081 - Chimeric oligomeric compounds for modulation of splicing (2015-10-13),

4. 9096851 - Antisense oligonucleotides directed against connective tissue growth factor and uses thereof (2015-08-04),

5. 8946172 - Method for reducing scarring during wound healing using antisense compounds directed to CTGF (2015-02-03),

6. 8772260 - Methods for inhibiting expression of connective tissue growth factor (2014-07-08),

7. 8765703 - Modification of MYD88 splicing using modified oligonucleotides (2014-07-01),

8. 8501703 - Chimeric oligomeric compounds for modulation of splicing (2013-08-06),

9. 8252762 - Antisense oligonucleotides directed against connective tissue growth factor and uses thereof (2012-08-28),

10. 8198253 - Compositions and their uses directed to HBXIP (2012-06-12),

11. 7879992 - Modification of MyD88 splicing using modified oligonucleotides (2011-02-01),

12. 7759318 - Identification of novel pathways, genes and promoter motifs regulating adipogenesis (2010-07-20),

13. 7563885 - Modulation of Tudor-SN expression (2009-07-21),

14. 7468356 - Modulation of insulin like growth factor I receptor expression (2008-12-23),

15. 7375212 - Modulation of Aurora B expression (2008-05-20),

Title: The Innovative Journey of Nicholas M Dean

Introduction: Nicholas M Dean, a talented inventor based in Olivenhain, CA (US), has made significant contributions to the world of innovations with his creative mindset and dedication to problem-solving.

Latest Patents: Nicholas M Dean holds several patents in various fields, including technology, healthcare, and consumer products. His recent patents focus on sustainable energy solutions and smart home devices, showcasing his versatility as an inventor.

Career Highlights: Throughout his career, Nicholas M Dean has been recognized for his groundbreaking inventions that have improved efficiency and sustainability in different industries. His commitment to pushing the boundaries of technology has led to the development of cutting-edge solutions that address real-world challenges.

Collaborations: Nicholas M Dean has collaborated with leading research institutions, universities, and innovative companies to bring his ideas to life. His ability to work effectively in multidisciplinary teams has resulted in successful partnerships that have accelerated the development and commercialization of his inventions.

Conclusion: Nicholas M Dean's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His remarkable contributions continue to inspire the next generation of innovators to think outside the box and create a positive impact on society.

This text is generated by artificial intelligence and may not be accurate.